Biotechnology companies are marked by their ongoing need for capital as they seek to address unmet medical needs with innovative products. Underscoring TRG’s counsel to the life sciences sector is its strong scientific knowledge to provide clients with sophisticated message development, media relations and investor relations. Our programs are proactive and highlight clinical milestones, scientific differentiators and medical meeting activity. We specialize in milestone visibility, clinical trial enrollment acceleration, data presentation, advocacy group relationships, scientific meeting coordination and exposure in key trade and business media outlets. Our on-staff medical PhD brings in-depth scientific expertise for scientific writing, messaging and milestone strategies.
As the population ages and the U.S. healthcare systems becomes increasingly overburdened, healthcare services companies have been receiving greater and more focused attention as they strive to provide patients with the highest quality of care, while minimizing costs. With a strong portfolio of healthcare services companies, the TRG team is well versed in this space and highly skilled in crafting messages that resonate across a broad spectrum of constituencies. We work daily with the investors and analysts that are focused on this industry as they seek new investment ideas for participating in this important and growing sub segment of healthcare. We closely track issues that are important to both our clients and their investors - the ever changing landscape of reimbursement, the paradigm shift related to healthcare reform, budgetary pressures on Medicare/Medicaid. Being closely in tune with these issues, we can better communicate clients’ value proposition in overall healthcare system savings. Our team quickly and effectively provides strategic counsel that works to our clients’ advantage.
With shifting FDA regulations and reimbursement issues, the medical technology/device arena faces constant challenges. Communicating in this environment requires not only a knowledge of the macro sector, but a clear understanding of the competitive nature of the industry and the need for clear technology differentiation and superiority to existing therapies. The TRG medical technology team is premiere in providing emerging companies the broadest suite of communications services aimed at specific initiatives for clinical trial enrollment acceleration, physician adoption, patient awareness and investor interest. Our leadership partnering with orthopedics/spine, cardiology and radiology companies is unsurpassed.
The evolving arena of healthcare IT offers innovative solutions to increase healthcare delivery efficiencies empower consumers with medical information and reduce costs. A major challenge is differentiating services, attracting new customers, outlining advantages of the new paradigms and discussing how these new services can bend the cost curve of healthcare. Our experience covers all of these issues including translating these to effective messages for investors and analysts.
The Ruth Group welcomes inquiries
from prospective clients, employees
and partners. If you would like a
representative to contact you,
please e-mail firstname.lastname@example.org.